Monitoring after a device is placed on the market
Published:
Changes
Manufacturers of medical devices must establish a post-market surveillance system as part of their quality management system.
This system must ensure that data on the medical device quality, safety, and performance are collected throughout its lifetime. These data provide important input for the manufacturer’s identification and implementation of preventive and corrective actions. The purpose is to ensure that devices placed on the market are safe to use.
Requirements for Post-Market Surveillance
The post-market surveillance system must be based on a plan, and the manufacturer must prepare a report on the surveillance of the device. The requirements for the report depend on the device's risk class.
More detailed information on the requirements for post-market surveillance can be found in Art. 83-86 MDR/ Art. 78-81 IVDR, and Annex III. Below is a summary of the main requirements relating to the surveillance plan and reporting.
Post-Market Surveillance Plan
This plan must describe how the relevant data will be collected and used, including data relating to serious incidents and user complaints. Specific requirements are outlined in Annex III, Section 1.
Report on Post-Market Surveillance for Lower-Risk Devices
This applies to Class I medical devices and Class A and B in vitro diagnostic medical devices.
The report must summarise the results and conclusions of the post-market surveillance data, describe and justify any preventive and corrective measures. The report must be updated as needed. The report must be made available to the Norwegian Medical Products Agency upon request.
Periodic Safety Update Report (PSUR) for Higher-Risk Devices
This applies to Class IIa, IIb, and III medical devices, and Class C and D in vitro diagnostic medical devices.
The report must summarise the results and conclusions of the post-market surveillance data, describe and justify any preventive and corrective measures. The report must be updated as needed. The report must be made available to the notified body involved in the conformity assessment, and the Norwegian Medical Products Agency upon request.
Relevant EU Guidance Documents
The European Commission and MDCG publish guidance documents on medical devices.
The following guidance related to market and safety surveillance are published:
- MDCG 2022-21 Guidance on Periodic Safety Update Report (PSUR) according to Regulation (EU) 2017/745
- MDCG 2025–10 Guidance on post-market surveillance of medical devices and in vitro diagnostic medical devices